- Home
- PEPG vs KUKE Comparison
PEPG vs KUKE Comparison
Compare PEPG & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- KUKE
- Stock Information
- Founded
- PEPG 2018
- KUKE 2002
- Country
- PEPG United States
- KUKE China
- Employees
- PEPG N/A
- KUKE N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- KUKE Other Consumer Services
- Sector
- PEPG Health Care
- KUKE Real Estate
- Exchange
- PEPG Nasdaq
- KUKE Nasdaq
- Market Cap
- PEPG 45.9M
- KUKE 42.0M
- IPO Year
- PEPG 2022
- KUKE 2021
- Fundamental
- Price
- PEPG $2.56
- KUKE $1.26
- Analyst Decision
- PEPG Buy
- KUKE
- Analyst Count
- PEPG 4
- KUKE 0
- Target Price
- PEPG $7.25
- KUKE N/A
- AVG Volume (30 Days)
- PEPG 633.9K
- KUKE 35.0K
- Earning Date
- PEPG 11-06-2025
- KUKE 10-15-2025
- Dividend Yield
- PEPG N/A
- KUKE N/A
- EPS Growth
- PEPG N/A
- KUKE N/A
- EPS
- PEPG N/A
- KUKE N/A
- Revenue
- PEPG N/A
- KUKE $9,442,397.00
- Revenue This Year
- PEPG N/A
- KUKE N/A
- Revenue Next Year
- PEPG N/A
- KUKE N/A
- P/E Ratio
- PEPG N/A
- KUKE N/A
- Revenue Growth
- PEPG N/A
- KUKE N/A
- 52 Week Low
- PEPG $0.88
- KUKE $1.33
- 52 Week High
- PEPG $9.94
- KUKE $10.00
- Technical
- Relative Strength Index (RSI)
- PEPG 74.19
- KUKE 27.67
- Support Level
- PEPG $1.82
- KUKE $1.43
- Resistance Level
- PEPG $2.24
- KUKE $1.54
- Average True Range (ATR)
- PEPG 0.28
- KUKE 0.16
- MACD
- PEPG 0.09
- KUKE -0.01
- Stochastic Oscillator
- PEPG 97.64
- KUKE 12.92
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.